Additionally, CRISPR-mediated CD38 knockout combined with CD38-CAR mRNA in NAM-cultured NK cells produced fratricide-resistant effectors with enhanced lysis of CD38+ MM cells [282]. The gene discussed is CD38; the disease is Miyoshi myopathy.